v3.26.1
Stock Compensation Expense (Tables)
 12 Months Ended
Mar. 31, 2026
Stock Compensation Expense [Abstract]  
Schedule of Assumptions Fair Value of Option Grants

The assumptions utilized in determining the fair value of option grants during the years ended March 31, 2026 and 2025, are as follows:

 

    2026     2025  
Exercise Price - ISOs     n/a       1.66  
Exercise Price - NQSOs     n/a       1.66  
Dividend Yield     n/a       0 %
Volatility     n/a       80 %
Risk-free Rate - ISOs     n/a       4.36 %
Risk-free Rate - NQSOs     n/a       4.36 %
Years to Expiration - ISOs     n/a       5  
Years to Expiration - NQSOs     n/a       5  
Schedule of Information Related to Stock Options

Vesting generally occurs over a period of three to four years for employees and two to three years for non-employee consultants. A summary of information related to stock options for the years ended March 31, 2026 and 2025, is as follows:

 

    2026     2025  
    Shares     Price     Shares     Price  
Outstanding - Beginning of Period     2,218,728     $ 1.40       2,232,008     $ 0.33  
Granted     -       1.66       1,635,000       1.66  
Exercised     (10,720 )     -       -       -  
Forfeited     -       0.55       (370,625 )     0.55  
Expired     (19,258 )     0.11       (1,277,655 )     0.11  
Outstanding - End of Period     2,188,750     $ 1.40       2,218,728     $ 1.40  
Exercisable at End of Period     2,033,125     $ 1.42       2,069,561     $ 1.42  
Weighted average duration to expiration of outstanding options at period-end (years)     7.4               8.3          
Weighted average grant date fair value     n/a             $ 0.76